Take a look at our Psoriasis Academy and learn more about:
- The mission of the Psoriasis Academy as a platform for sharing clinical experience
- Expert opinions on psoriasis management and treatment
- The goals of the Academy, including sharing the latest hot topics and developments
The Psoriasis Academy draws on the experience of practicing dermatologists, general practitioners (GPs), and allied healthcare professionals (HCPs) around the world. It is a central repository for specialists who know the current market, but want to remain informed on the latest treatment research and development. The Psoriasis Academy aims to serve as a platform for HCPs to share clinical experiences.
Psoriasis is a debilitating, chronic inflammatory autoimmune disease, with an evolving treatment landscape that includes topical therapy, phototherapy, and systemic drugs1.
The Psoriasis Academy was created because we know that busy HCPs need to access and share important information on all aspects of the disease and its management quickly and easily.
What we are striving for
The Psoriasis Academy is an online educational resource that has been created to help HCPs quickly learn the latest hot topics and developments in the field, and to help them navigate the rapidly evolving treatment landscape for patients with moderate-to-severe psoriasis.
Throughout the Psoriasis Academy, look out for video footage of leading experts in the Psoriasis field. Our experts have answered insightful questions on aspects of Psoriasis management, which we have included throughout the Psoriasis Academy. Stay tuned for their ‘top tips’, and video highlights from the Almirall-sponsored symposium at the 30th EADV congress, ‘Are you wasting your time getting to PASI 100? Come and listen to the brain fight with the skin’, and the 28th EADV Congress 2019.
Find out more about our Psoriasis key opinion leaders and their experience in this exciting field. Watch their video introductions in the next section below.
Meet the Experts
Professor Peter van de Kerkhof
Senior Professor of Dermatology at the Radboud University Nijmegen Medical Centre, Netherlands.
Professor Peter van de Kerkhof received honorarium from EPG Health to create content for this resource.
Professor Diamant Thaçi
Professor and Director at the Comprehensive Centre for Inflammation Medicine at the University of Lübeck in Germany, and Chair of the Inflammatory Board at the Lübeck campus of University Hospital Schleswig-Holstein.
Professor Thaçi has extensive research experience in the field of immunology, and has been involved in more than 300 clinical trials.
Professor Diamant Thaçi received honorarium from EPG Health to create content for this resource.
Professor Nehal Mehta
Professor Nehal Mehta is a preventive cardiologist and nuclear cardiologist at the National Heart, Blood and Lung Institute in Bethesda, USA.
Professor Mehta is an advocate of interdisciplinary cooperation to tackle the issue of comorbidities in patients with psoriasis.
Professor Nehal Mehta received honorarium from EPG Health to create content for this resource.
Professor Mrowietz is Professor of Dermatology and Head of the Psoriasis-Center at the University Medical Centre in Kiel, Germany.
Professor Mrowietz has extensive experience treating people with psoriasis, and has co-authored recommendations for systemic therapy in persons with psoriasis during the pandemic phase of SARS-CoV-2 (available as an external link).
Professor Ulrich Mrowietz received honorarium from EPG Health to create content for this resource.
Associate Professor Jordi Quoidbach
Associate Professor Quoidbach is based in the Department of People Management and Organisation, at Ramon Llull University, in Barcelona, Spain. Quoidbach specialises in emotion and decision-making.
Associate Professor Jordi Quoidbach received honorarium from EPG Health to create content for this resource.
Dr Julia-Tatjana Maul
Dr Maul is Senior Dermatologist and Head of the Psoriasis Clinic and clinical trials team at the University Hospital of Zürich, Switzerland.
Dr Maul is principal investigator of the Swiss Dermatology Network for Targeted Therapy (SDNTT) and has contributed to the Global Psoriasis Atlas (GPA), a 3-month study of psoriasis epidemiology and access to healthcare, for people with psoriasis in South America. In October 2019, Dr Maul officially joined the GPA team as a medical coordinator.Dr Maul received honorarium from EPG Health to create content for this resource.
Dr Christian Greis
Dr Greis is a dermatologist at the University Hospital of Zürich, Switzerland, and founder of the teledermatology platform derma2go.
Dr Greis is currently completing a Master of Business Administration in digital medicine at the Institute for Communication and Leadership (IKF) in Lucerne.Dr Greis received honorarium from EPG Health to create content for this resource.
Professor Ricardo Romiti
Professor Romiti is a clinical Professor of Dermatology and Head of the Psoriasis Unit at the University Hospital of São Paulo, Brazil.
Professor Romiti is responsible for the psoriasis department of the Brazilian Society for Dermatology, a regional coordinator of the Global Psoriasis Atlas in Latin America, and a board member of the International Psoriasis Council.Professor Romiti received honorarium from EPG Health to create content for this resource.
- Feldman SR, Goffe B, Rice G, Mitchell M, Kaur M, Robertson D, et al. The challenge of managing psoriasis: Unmet medical needs and stakeholder perspectives. Am Heal Drug Benefits. 2016;9(9):504–512.
The Psoriasis Management, Psoriasis Treatment and Psoriasis Guidelines content has been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Almirall S.A, who have had no editorial input into the content. EPG Health received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
The Expert Opinion and PsoMOT content has been developed by EPG Health for Medthority in collaboration with the sponsor Almirall S.A., utilising content from their Almirall funded symposium at EADV 2021 and PsoMOT meeting in November 2019.